-
Diagnostics World News | The value of liquid biopsies in precision medicine, particularly for managing cancers where tissue samples from tumors and metastatic sites are hard if not impossible to obtain, is a major topic of conversation, as tests that look for circulating tumor cells and circulating tumor DNA are enjoying a "resurgence" in clinical trials.
Oct 29, 2019
-
Diagnostics World News | The world of medicine is continually seeking new methods to improve health outcomes through a variety of innovative mechanisms, and accelerated diagnostics is no exception. Now, scientists may have a faster, easier way to diagnose and catch certain diseases earlier thanks to a new dopamine detector.
Oct 24, 2019
-
Diagnostics World News | A trio of sessions at the 2019 Next Generation Dx Summit in August focused on laboratory developed tests (LDTs)—in vitro diagnostic tests designed, manufactured and used within a single laboratory—and incited lively debate about proposed regulation under the VALID Act.
Oct 22, 2019
-
MIT News | MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells. These engineered phages are less likely to provoke resistance in bacteria, and could help to overcome antibiotic resistance.
Oct 21, 2019
-
Diagnostics World News | Sensors are revolutionizing healthcare and the presenters at the Sensors Summit 2019 are taking three days to show just how much.
Oct 17, 2019
-
Diagnostics World News | At the 2019 Next Generation Dx Summit in August, a staff fellow with the FDA shared the agency's approach to evaluating medical devices enabled by "adaptive" artificial intelligence and machine learning—meaning they continuously learn as they're exposed to more data.
Oct 16, 2019
-
Diagnostics World News | The FDA has been unusually busy over the past two years on programs and projects advancing regulatory science around in vitro diagnostics, including digital pathology.
Oct 15, 2019
-
STAT | Men account for about 1% or less of all breast cancer diagnoses in the U.S., yet male breast cancer patients have a 19% higher mortality rate than their diagnosed female counterparts, according to a recent study in JAMA Oncology.
Oct 11, 2019
-
Diagnostics World News | Due to opposing market forces and technology innovation in both the central lab and point-of-care diagnostics settings, overall diagnostic testing is trending more slowly toward decentralization than some might expect, according to Berkeley, California-based diagnostics consultant Lucy Hattingh.
Oct 10, 2019